In this issue:
Long-term risks of gene therapy
Molecular dissection of CAR-T cells
CT-0508 for HER2 overexpressing tumours
Efficacy, safety, and feasibility of huCART19-IL18
Activity of anti-GPRC5D CAR T-cells
CISH-knockout TILs
Phase 1 results of cema-cel
Three-year follow-up of ZUMA-12
T cell responses after the influenza vaccination
CD19 CAR-T therapy among older patients
Please login below to download this issue (PDF)